Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 19 | 2025 | 403 | 3.860 |
Why?
|
| Epigenesis, Genetic | 8 | 2025 | 291 | 2.930 |
Why?
|
| Obesity | 6 | 2025 | 1151 | 1.750 |
Why?
|
| Mental Health | 3 | 2025 | 385 | 1.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 760 | 1.130 |
Why?
|
| Social Support | 2 | 2025 | 445 | 0.880 |
Why?
|
| Monocytes | 3 | 2022 | 277 | 0.870 |
Why?
|
| Hawaii | 8 | 2025 | 2011 | 0.840 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 30 | 0.820 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 81 | 0.810 |
Why?
|
| Biomedical Research | 3 | 2024 | 502 | 0.800 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 192 | 0.800 |
Why?
|
| Behavior, Animal | 2 | 2025 | 373 | 0.790 |
Why?
|
| MicroRNAs | 3 | 2024 | 518 | 0.730 |
Why?
|
| Social Class | 1 | 2024 | 291 | 0.720 |
Why?
|
| Life Style | 1 | 2024 | 334 | 0.720 |
Why?
|
| Humans | 37 | 2025 | 43102 | 0.690 |
Why?
|
| Immunity | 1 | 2021 | 61 | 0.680 |
Why?
|
| Depression | 2 | 2025 | 863 | 0.670 |
Why?
|
| Cytokines | 1 | 2024 | 678 | 0.640 |
Why?
|
| Genetic Markers | 1 | 2019 | 150 | 0.580 |
Why?
|
| Health Status Disparities | 2 | 2024 | 719 | 0.570 |
Why?
|
| Cytosine | 2 | 2016 | 33 | 0.570 |
Why?
|
| Insulin Resistance | 1 | 2019 | 201 | 0.520 |
Why?
|
| Central Nervous System | 1 | 2016 | 152 | 0.460 |
Why?
|
| Diet | 1 | 2021 | 826 | 0.450 |
Why?
|
| Semiconductors | 1 | 2015 | 12 | 0.450 |
Why?
|
| Genome | 2 | 2015 | 149 | 0.430 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 515 | 0.430 |
Why?
|
| Male | 15 | 2025 | 23409 | 0.430 |
Why?
|
| Brain | 3 | 2025 | 1472 | 0.430 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 8 | 0.410 |
Why?
|
| HIV Infections | 2 | 2019 | 2586 | 0.400 |
Why?
|
| CpG Islands | 7 | 2024 | 109 | 0.400 |
Why?
|
| Exons | 1 | 2013 | 92 | 0.390 |
Why?
|
| Alternative Splicing | 1 | 2013 | 94 | 0.390 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.390 |
Why?
|
| Middle Aged | 9 | 2025 | 12222 | 0.390 |
Why?
|
| Cohort Studies | 4 | 2025 | 1759 | 0.380 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 423 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 526 | 0.340 |
Why?
|
| Conserved Sequence | 2 | 2010 | 122 | 0.330 |
Why?
|
| Genome, Human | 2 | 2013 | 144 | 0.330 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 12 | 0.330 |
Why?
|
| Pilot Projects | 2 | 2024 | 760 | 0.320 |
Why?
|
| Histones | 4 | 2013 | 197 | 0.320 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1070 | 0.300 |
Why?
|
| Animals | 13 | 2025 | 16992 | 0.280 |
Why?
|
| Inflammation | 2 | 2024 | 758 | 0.270 |
Why?
|
| Aged | 5 | 2025 | 8214 | 0.260 |
Why?
|
| Adult | 7 | 2025 | 13872 | 0.250 |
Why?
|
| Adolescent | 5 | 2025 | 6081 | 0.250 |
Why?
|
| Mice | 10 | 2025 | 6644 | 0.230 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 11 | 0.230 |
Why?
|
| Entamoeba histolytica | 1 | 2024 | 5 | 0.220 |
Why?
|
| Genome, Protozoan | 1 | 2024 | 13 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1596 | 0.220 |
Why?
|
| Neural Pathways | 1 | 2025 | 138 | 0.210 |
Why?
|
| Organ Specificity | 3 | 2016 | 141 | 0.210 |
Why?
|
| HCT116 Cells | 2 | 2015 | 40 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1869 | 0.210 |
Why?
|
| Child, Preschool | 3 | 2024 | 1546 | 0.210 |
Why?
|
| Employment | 1 | 2025 | 86 | 0.210 |
Why?
|
| Self Concept | 1 | 2025 | 171 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 386 | 0.200 |
Why?
|
| Food | 1 | 2023 | 103 | 0.190 |
Why?
|
| Food Supply | 1 | 2023 | 122 | 0.180 |
Why?
|
| Pregnancy | 2 | 2025 | 1772 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2024 | 1600 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 8 | 0.180 |
Why?
|
| Vaccines | 1 | 2022 | 65 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2021 | 51 | 0.170 |
Why?
|
| Cell Line | 4 | 2013 | 1410 | 0.170 |
Why?
|
| Simvastatin | 1 | 2021 | 29 | 0.170 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 37 | 0.170 |
Why?
|
| Disease Progression | 1 | 2024 | 667 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 247 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 1234 | 0.160 |
Why?
|
| Lyases | 1 | 2021 | 56 | 0.160 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1063 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 140 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 734 | 0.160 |
Why?
|
| Neuroglia | 1 | 2020 | 133 | 0.150 |
Why?
|
| Selenoproteins | 1 | 2021 | 155 | 0.150 |
Why?
|
| Young Adult | 3 | 2025 | 5080 | 0.150 |
Why?
|
| Gene Silencing | 3 | 2010 | 154 | 0.150 |
Why?
|
| Aging | 1 | 2024 | 783 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 316 | 0.140 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 3 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 149 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2020 | 210 | 0.140 |
Why?
|
| Child | 2 | 2024 | 3443 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 158 | 0.140 |
Why?
|
| Liver | 1 | 2021 | 511 | 0.140 |
Why?
|
| Triglycerides | 1 | 2018 | 147 | 0.130 |
Why?
|
| Oligodendroglioma | 2 | 2008 | 6 | 0.130 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 7 | 0.120 |
Why?
|
| Mutation | 2 | 2024 | 1177 | 0.120 |
Why?
|
| Logistic Models | 1 | 2019 | 1009 | 0.120 |
Why?
|
| HIV | 1 | 2016 | 100 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1285 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2010 | 321 | 0.120 |
Why?
|
| Chromatin | 3 | 2013 | 186 | 0.120 |
Why?
|
| DNA Replication | 2 | 2013 | 148 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 107 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 72 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 310 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 140 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2015 | 41 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 863 | 0.110 |
Why?
|
| Self Care | 1 | 2015 | 175 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2013 | 346 | 0.100 |
Why?
|
| Histone Demethylases | 1 | 2013 | 8 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2013 | 30 | 0.100 |
Why?
|
| Phenotype | 2 | 2018 | 780 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 352 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 1024 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2011 | 48 | 0.080 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 11 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2010 | 58 | 0.080 |
Why?
|
| Japan | 2 | 2021 | 348 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 211 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2021 | 1035 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2010 | 83 | 0.080 |
Why?
|
| Environment | 1 | 2010 | 149 | 0.070 |
Why?
|
| Nicotine | 2 | 2024 | 302 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2008 | 74 | 0.070 |
Why?
|
| Cadherins | 1 | 2007 | 102 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 15 | 0.060 |
Why?
|
| Astrocytoma | 1 | 2005 | 17 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2025 | 18 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2005 | 35 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2025 | 27 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 61 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 113 | 0.060 |
Why?
|
| Receptors, Peptide | 1 | 2024 | 24 | 0.050 |
Why?
|
| Virulence | 1 | 2024 | 246 | 0.050 |
Why?
|
| Gene Expression | 2 | 2008 | 701 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2024 | 125 | 0.050 |
Why?
|
| Camptothecin | 1 | 2003 | 21 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 93 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 191 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2022 | 23 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 30 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 74 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 15 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2024 | 430 | 0.040 |
Why?
|
| Philippines | 1 | 2021 | 81 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 42 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 134 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 100 | 0.040 |
Why?
|
| Creatinine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Neurons | 1 | 2008 | 1263 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2021 | 112 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 140 | 0.040 |
Why?
|
| Selenium | 1 | 2021 | 155 | 0.040 |
Why?
|
| United States | 2 | 2022 | 5205 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 258 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 972 | 0.040 |
Why?
|
| Grooming | 1 | 2018 | 5 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 587 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1175 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 39 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 54 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 704 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 161 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 222 | 0.030 |
Why?
|
| Neural Tube | 1 | 2016 | 8 | 0.030 |
Why?
|
| Ectoderm | 1 | 2016 | 12 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 23 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 49 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 57 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 98 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 157 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 719 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1568 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 2544 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 968 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 456 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 508 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 257 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 300 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 205 | 0.030 |
Why?
|
| RNA | 1 | 2016 | 266 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 219 | 0.030 |
Why?
|
| Replication Origin | 1 | 2013 | 16 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 385 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2853 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 1092 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 31 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 37 | 0.020 |
Why?
|
| S Phase | 1 | 2013 | 36 | 0.020 |
Why?
|
| Genes, rRNA | 1 | 2013 | 14 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 119 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2013 | 29 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 45 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 64 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2013 | 68 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 652 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 561 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 712 | 0.020 |
Why?
|
| Telomere | 1 | 2013 | 59 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 424 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2011 | 68 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 735 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 465 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 293 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2676 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 99 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 532 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2007 | 88 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 207 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 536 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 8 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 455 | 0.010 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2005 | 12 | 0.010 |
Why?
|
| Retroviridae | 1 | 2005 | 25 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 73 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 49 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 983 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 638 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 165 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1542 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 19 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 665 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 195 | 0.010 |
Why?
|
| Computers | 1 | 2002 | 35 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 411 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 458 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 307 | 0.010 |
Why?
|
| Software | 1 | 2002 | 236 | 0.010 |
Why?
|
| Computational Biology | 1 | 2002 | 327 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1271 | 0.010 |
Why?
|